Search company, investor...

Predict your next investment

Venture Capital
legendstar.com.cn

Investments

266

Portfolio Exits

13

Funds

6

About Legend Star

Legend Star, a venture capital subsidiary of Legend Holdings, focuses on early-stage angel investments and in-depth incubation. It mainly invests in areas such as artificial intelligence, TMT, and healthcare.

Headquarters Location

4/F No.39 Haidian West Street, Haidian District

Beijing, Beijing, 100080,

China

+86-10-8298-2599

Want to inform investors similar to Legend Star about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Legend Star News

Adlai Nortye Raises $100 Million In Series D Financing

Dec 22, 2022

Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of a $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing is participated by Legend Star, Wuxi Biologicals Healthcare Ventures, Triwise Capital, Qingdao Mukui, Guolian Industrial Investment, Tian Ge Interactive, etc. Proceeds from the financing will be used to accelerate the development of ongoing clinical and preclinical programs, expand drug portfolio through in-house R&D capability, in-licensing, mergers, and acquisitions, and other strategic collaborations. "We intend to develop differentiated and innovative oncology drugs globally to address the unmet medical needs and aspire to transform deadly cancer into a chronic and eventually a curable disease," said Carsten Lu, President, and CEO of Adlai Nortye. "This round of financing represents an important milestone for Adlai Nortye, and we are honored to continue gaining support from our prestigious new and existing investors as Adlai Nortye has demonstrated a proven track record of delivering what we promised to the market and investors in the previous rounds. We are well-positioned to advance the development of our robust therapeutics pipeline and looking forward to bringing in more and more innovative treatments benefiting patients globally." "We have strong conviction in innovation and paying close attention to what is trending in the biopharmaceutical industry," said Dazhong Lv, Managing Director of SDIC Fund Management. "Adlai Nortye's strategic vision in global market, dedication to innovation in research, and strong execution capability are what have been attracting us. We are pleased to have the opportunity to lead Adlai Nortye's D round and look forward to the development of multiple first-in-class drugs from the company's innovative pipeline globally and in China." Yan Leng, partner of Legend Star added, "Adlai Nortye is quickly emerging as a leader in the field of oncology and we are delighted to have invested in Adlai Nortye and provided support for the R&D of the company's promising pipeline. Combining innovative research and advanced clinical assets with proven management experience, Adlai Nortye has built an exciting portfolio filled with opportunities. We are excited to join such an experienced and proven management team, an outstanding group of investors, and top-tier pharmaceutical partners to advance the company's pipeline products." Share this article:

Legend Star Investments

266 Investments

Legend Star has made 266 investments. Their latest investment was in Leishen Intelligent as part of their Series B on January 1, 2023.

CBI Logo

Legend Star Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/3/2023

Series B

Leishen Intelligent

Yes

1

11/29/2022

Series A

Rgenta Therapeutics

$52M

No

12

9/19/2022

Seed VC

CarbonSiliconAI

$7M

Yes

1

6/16/2022

Seed VC

Subscribe to see more

Subscribe to see more

10

5/26/2022

Seed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/3/2023

11/29/2022

9/19/2022

6/16/2022

5/26/2022

Round

Series B

Series A

Seed VC

Seed VC

Seed VC - III

Company

Leishen Intelligent

Rgenta Therapeutics

CarbonSiliconAI

Subscribe to see more

Subscribe to see more

Amount

$52M

$7M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

12

1

10

10

Legend Star Portfolio Exits

13 Portfolio Exits

Legend Star has 13 portfolio exits. Their latest portfolio exit was Singsound on November 08, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/8/2021

Acquired

$99M

1

10/27/2021

Acquired

$99M

8

7/8/2021

IPO

$99M

Public

2

3/15/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/11/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/8/2021

10/27/2021

7/8/2021

3/15/2021

6/11/2020

Exit

Acquired

Acquired

IPO

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

8

2

10

10

Legend Star Fund History

6 Fund Histories

Legend Star has 6 funds, including 四期人民币基金 (RMB Fund IV).

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/30/2020

四期人民币基金 (RMB Fund IV)

$119.18M

1

2/2/2018

Legend Star Fund III

$99M

10

1/15/2013

Suzhou Xinglian Tongdao Angel Investment Center LP

Subscribe to see more

Subscribe to see more

$99M

10

12/1/2009

Legend Star Angel Fund

Subscribe to see more

Subscribe to see more

$99M

10

Tibet Starlight Galaxy Investment Center

Subscribe to see more

Subscribe to see more

10

Closing Date

9/30/2020

2/2/2018

1/15/2013

12/1/2009

Fund

四期人民币基金 (RMB Fund IV)

Legend Star Fund III

Suzhou Xinglian Tongdao Angel Investment Center LP

Legend Star Angel Fund

Tibet Starlight Galaxy Investment Center

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$119.18M

$99M

$99M

$99M

Sources

1

10

10

10

10

Legend Star Team

2 Team Members

Legend Star has 2 team members, including current Managing General Partner, Xudong Tang.

Name

Work History

Title

Status

Xudong Tang

Managing General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Xudong Tang

Subscribe to see more

Work History

Title

Managing General Partner

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.